Programmed Cell Death in Cancer Progression and Therapy, in Advances in Experimental Medicine and Biology, Vol. 615

A.A. Philchenkov

首页> 外文期刊>Biochemistry >Programmed Cell Death in Cancer Progression and Therapy, in Advances in Experimental Medicine and Biology, Vol. 615

【24h】

Programmed Cell Death in Cancer Progression and Therapy, in Advances in Experimental Medicine and Biology, Vol. 615

机译：癌症进展和治疗中的程序性细胞死亡，《实验医学和生物学进展》，第1卷。 615

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Programmed cell death (PCD) is an intriguing term that was introduced by Richard Lockshin nearly 45 years ago. As we know now, several alternative genetic programs of cell death exist and their basic mechanisms are largely different although partially interconnecting. Generally speaking, this book is about PCD with intense focus on apoptosis and the exploitation of PCD for treating cancer.

机译：程序性细胞死亡（PCD）是一个有趣的术语，由Richard Lockshin于45年前提出。众所周知，存在一些细胞死亡的替代遗传程序，尽管部分相互联系，但它们的基本机制却大不相同。一般而言，这本书是关于PCD的，主要关注细胞凋亡和PCD在治疗癌症中的应用。

著录项

来源
《Biochemistry》 |2009年第4期|共2页
作者
A.A. Philchenkov;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物化学;
关键词

相似文献

外文文献
中文文献
专利

1. Programmed cell death in cancer progression and therapy, in advances in experimental medicine and biology, Vol. 615; (R. Khosravi-Far and E. White, eds., Springer, 2008, 356 p, 119.95 Euro) [J] . A A Philchenkov Biochemistry . 2009,第4期

机译：程序性细胞死亡在癌症进展和治疗中的进展，在实验医学和生物学进展中，第1卷。 615; （R.Khosravi-Far和E.White编辑，施普林格，2008，356羽，119.95欧元）
2. Advances in Experimental Medicine and Biology, vol. 842, Biochemical Roles of Eukaryotic Cell Surface Macromolecules [J] . Stocker Bridget L. Chembiochem: A European journal of chemical biology . 2015,第5期

机译：实验医学和生物学进展，第一卷。 842，真核细胞表面大分子的生化作用
3. Recent advances of immunotherapy in lung cancer: anti-programmed cell death-1/programmed death ligand-1 antibodies [J] . Lu-Lu Yang, Yi-Long Wu Lung cancer management. . 2014,第2期

机译：肺癌免疫疗法的最新进展：抗程序性细胞死亡1 /程序性死亡配体1抗体
4. Changes in the Type of Circulating Cancer Associated Macrophage Like Cells During and After Radiation Therapy is Associated with Progression in Thoracic Cancers [C] . Daniel L. Adams International Molecular Medicine Tri-Conference. . 2019

机译：在放射治疗期间和后，循环癌症相关巨噬细胞类型的变化与胸癌的进展相关
5. Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer [D] . Ogura Atsushi, 小倉淳司 2019

机译：直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
6. PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response Progression-Free Survival and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors [O] . Foteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, 2020

机译：PIOS（Patras免疫治疗评分）评分与接受抗程序性细胞死亡1（PD）治疗的晚期非小细胞肺癌（NSCLC）患者的最佳总体缓解率无进展生存期和免疫治疗后总体生存率相关-1）抑制剂
7. PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors [O] . Foteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, 2020

机译：PIO（Patras免疫疗法评分）得分与抗议细胞死亡-1（PD）治疗的先进的非小细胞肺癌（NSCLC）患者的最佳整体反应，无进展生存和免疫治疗的总生存相关（PD -1）抑制剂
8. Validating Conditionally Reprogrammed Cells to Advance Personalized Medicine for Prostate Cancer. [R] . Albanese, C., Feldman, A., Petricoin, E. 2017

机译：验证有条件的重编程细胞推进前列腺癌的个性化医疗。

Programmed Cell Death in Cancer Progression and Therapy, in Advances in Experimental Medicine and Biology, Vol. 615

摘要

著录项

相似文献

相关主题

期刊订阅